StockMacro
Menu

Erasca

$13.61 +18% in 6 monthsMarket cap $4.8B

ERAS on XNAS, Health Care, Erasca, Inc., job postings

Measures activity, not value. Not investment advice.

Shares rose 390% in a year while the company lost $307.9M over 12 months.

  • WatchCash reserves $947.8M, net cash the same $947.8M
  • BadShort interest 11% of shares, 8.9 days to cover

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Its focused RAS/MAPK pathway pipeline comprises modality-agnostic programs aligned with three therapeutic strategies of: targeting key upstream and downstream signaling nodes in the RAS/MAPK pathway; targeting RAS directly; and targeting escape routes that emerge in response to treatment. Its pipeline includes two clinical-stage programs (ERAS-0015, a pan-RAS molecular glue; and ERAS-4001, a pan-KRAS inhibitor), and ERAS-12, a discovery-stage program.

Industry
Pharmaceutical preparations (Health Care)
Employees
103
Website
erasca.com
Listed
Nasdaq, US
Last results
12 Nov 2026
Next results
expected around 19 Jan 2027 (an estimate: a year ago it reported on 20 Jan 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: net loss $51.3M.
Quarter to 31 Dec 2021: revenue –, net income -$30.5MQuarter to 31 Mar 2022: revenue –, net income -$36.5MQuarter to 30 Jun 2022: revenue –, net income -$35.6MQuarter to 30 Sep 2022: revenue –, net income -$35.5MQuarter to 31 Dec 2022: revenue –, net income -$135.2MQuarter to 31 Mar 2023: revenue –, net income -$33.2MQuarter to 30 Jun 2023: revenue –, net income -$31.8MQuarter to 30 Sep 2023: revenue –, net income -$30.4MQuarter to 31 Dec 2023: revenue –, net income -$29.7MQuarter to 31 Mar 2024: revenue –, net income -$35.0MQuarter to 30 Jun 2024: revenue –, net income -$63.2MQuarter to 30 Sep 2024: revenue –, net income -$31.2MQuarter to 31 Dec 2024: revenue –, net income -$32.2MQuarter to 31 Mar 2025: revenue –, net income -$31.0MQuarter to 30 Jun 2025: revenue –, net income -$33.9MQuarter to 30 Sep 2025: revenue –, net income -$30.6MQuarter to 31 Dec 2025: revenue –, net income -$29.1MQuarter to 31 Mar 2026: revenue –, net income -$183.4MQuarter to 30 Jun 2026: revenue –, net income -$44.1MQuarter to 30 Sep 2026: revenue –, net income -$51.3M
31 Dec 2021RevenueNet incomeNet losstallest bar $183.4M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026–-$51.3M
30 Jun 2026–-$44.1M
31 Mar 2026–-$183.4M
31 Dec 2025–-$29.1M
30 Sep 2025–-$30.6M
30 Jun 2025–-$33.9M
31 Mar 2025–-$31.0M
31 Dec 2024–-$32.2M
30 Sep 2024–-$31.2M
30 Jun 2024–-$63.2M
31 Mar 2024–-$35.0M
31 Dec 2023–-$29.7M
30 Sep 2023–-$30.4M
30 Jun 2023–-$31.8M
31 Mar 2023–-$33.2M
31 Dec 2022–-$135.2M
30 Sep 2022–-$35.5M
30 Jun 2022–-$35.6M
31 Mar 2022–-$36.5M
31 Dec 2021–-$30.5M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. – –
Revenue growthRevenue of the last 12 months compared with the 12 months before. – +11%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$307.9M -$127.7M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). -$0.99 -$0.43
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. – – 73.2%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. – – -25.0%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. – – -18.2%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. -48.7% -58.8%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. – -$98.4M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $947.8M $362.4M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $0 $0
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). -$947.8M (net cash) -$362.4M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 0.0 0.0
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $2.61
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 19.3
P/SPrice to sales: market cap divided by revenue of the last 12 months. – 5.0
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. – 5.0
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 5.2 2.0

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
ErascaERAS (this company) $4.8Bloss–––
Dianthus TherapeuticsDNTH $4.8Bloss–––
PTC TherapeuticsPTCT $4.7Bloss4.1-35%-9.2%
LiquidiaLQDA $4.9Bloss7.9+798%-15.1%
Cogent BiosciencesCOGT $4.6Bloss–––
VeradermicsMANE $5.0Bloss–––

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

–

No data for this company

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+5.5%

270 13F filers vs 256

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

93%

327.1M shares held by 13F filers (30 Sep 2026) of 351.0M outstanding (5 Nov 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

11%

37.2M shares sold short (30 Oct 2026) of 351.0M outstanding (5 Nov 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

8.9

37.2M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

+0.5%

37.0M shares sold short in the report before, 37.2M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

55%

55% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 47%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

–

No data for this company

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

–

No data for this company

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

–

No data for this company

Lobbying What the company reported spending on federal lobbying over the last four quarters.

–

No data for this company

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

35

35 articles in the last 7 days; its usual week has 2 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

18×

35 articles in the last 7 days; its usual week has 2.

Price $13.61 on 20 Nov 2026, +390% over 12 months (12-month range $2.78 to $22.47)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders sold a net $2.3M in the last 12 months (the 12 months before: $0).
Capital spending per quarter. Capital spending $8K in the latest quarter, -73% on a year earlier.
Institutional holders (13F filers). 270 13F filers reported holding it in the latest 13F quarter, +96% on a year earlier.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, revenue per quarter, federal obligations, lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
16 Oct 20268-K and other filingsDirector or officer change
10 Aug 20268-K and other filingsDirector or officer change
10 Aug 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
19 May 2026Sharp changeMany funds opening a new position: many funds opening a new position, 85 vs usual 23.50 (2026-03-31); 3.4x the same period a year earlier
17 Dec 2024Sharp changeShort interest spike: short interest spike, 32.2M vs usual 12.5M (2024-11-29); 3.6x the same period a year earlier
3 Dec 2024Sharp changeShort interest spike: short interest spike, 32.1M vs usual 10.9M (2024-11-15); 3.7x the same period a year earlier
19 Nov 2024Sharp changeShort interest spike: short interest spike, 33.0M vs usual 10.6M (2024-10-31); 4.2x the same period a year earlier
29 Oct 2024Sharp changeShort interest spike: short interest spike, 33.7M vs usual 10.4M (2024-10-15); 4.6x the same period a year earlier
15 Oct 2024Sharp changeShort interest spike: short interest spike, 33.7M vs usual 10.3M (2024-09-30); 4.6x the same period a year earlier
1 Oct 2024Sharp changeShort interest spike: short interest spike, 27.0M vs usual 10.2M (2024-09-13); 3.2x the same period a year earlier
17 Sep 2024Sharp changeShort interest spike: short interest spike, 24.8M vs usual 10.1M (2024-08-30); 2.8x the same period a year earlier
27 Aug 2024Sharp changeShort interest spike: short interest spike, 23.4M vs usual 9.8M (2024-08-15); 2.7x the same period a year earlier
13 Aug 2024Sharp changeShort interest spike: short interest spike, 22.3M vs usual 9.8M (2024-07-31); 2.1x the same period a year earlier
30 Jul 2024Sharp changeShort interest spike: short interest spike, 21.8M vs usual 9.8M (2024-07-15); 2.0x the same period a year earlier
16 Jul 2024Sharp changeShort interest spike: short interest spike, 20.0M vs usual 9.8M (2024-06-28); 1.8x the same period a year earlier
2 Jul 2024Sharp changeShort interest spike: short interest spike, 15.3M vs usual 9.7M (2024-06-14); 1.6x the same period a year earlier
18 Jun 2024Sharp changeShort interest spike: short interest spike, 14.1M vs usual 9.7M (2024-05-31); 1.4x the same period a year earlier
16 May 20248-K and other filingsRestructuring costs announced
9 Dec 2023Sharp changeClustered insider buying: clustered insider buying (3 independent filers, 3 filing(s) in 30 days, value_usd total 1.8M)
10 Apr 20238-K and other filingsDirector or officer change
10 Apr 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
21 Dec 2022Sharp changeClustered insider buying: clustered insider buying (3 independent filers, 3 filing(s) in 30 days, value_usd total 2.3M)
27 Apr 20228-K and other filingsDirector or officer change
27 Apr 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
Insider net buying (open market)
Month from 1 Dec 2022: $2.4M published
Month from 1 Jan 2023: $232K published
Month from 1 Mar 2023: $284K published
Month from 1 Apr 2023: $55K published
Month from 1 Jun 2023: $275K published
Month from 1 Oct 2023: $2.0M published
Month from 1 Dec 2023: $1.8M published
Month from 1 May 2024: $182K published
Month from 1 Jan 2026: -$671K published
Month from 1 Mar 2026: -$301K published
Month from 1 Apr 2026: -$1.3M published
Capital spending per quarter
Quarter ended 31 Dec 2020: $25K; public on 25 Mar 2022
Quarter ended 31 Mar 2021: $122K; public on 13 May 2022
Quarter ended 31 Mar 2022: $7.3M, +5913% on a year earlier; public on 13 May 2022
Quarter ended 30 Jun 2022: $4.6M, +687% on a year earlier; public on 12 Aug 2022
Quarter ended 30 Sep 2022: $1.8M; public on 10 Nov 2022
Quarter ended 31 Dec 2022: $864K; public on 24 Mar 2023
Quarter ended 31 Mar 2023: $1.2M, -84% on a year earlier; public on 16 May 2023
Quarter ended 30 Jun 2023: $247K, -95% on a year earlier; public on 11 Aug 2023
Quarter ended 30 Sep 2023: $240K, -87% on a year earlier; public on 10 Nov 2023
Quarter ended 31 Dec 2023: $82K, -91% on a year earlier; public on 28 Mar 2024
Quarter ended 31 Mar 2024: $42K, -97% on a year earlier; public on 9 May 2024
Quarter ended 30 Jun 2024: $13K, -95% on a year earlier; public on 13 Aug 2024
Quarter ended 30 Sep 2024: $5K, -98% on a year earlier; public on 13 Nov 2024
Quarter ended 31 Mar 2025: $83K, +98% on a year earlier; public on 14 May 2025
Quarter ended 30 Jun 2025: $30K, +131% on a year earlier; public on 13 Aug 2025
Quarter ended 30 Sep 2025: $6K, +20% on a year earlier; public on 13 Nov 2025
Quarter ended 31 Dec 2025: $9K; public on 13 Mar 2026
Quarter ended 31 Mar 2026: $36K, -57% on a year earlier; public on 12 May 2026
Quarter ended 30 Jun 2026: $8K, -73% on a year earlier; public on 12 Aug 2026
Institutional holders (13F filers)
31 Dec 2021 report: 56; public on 14 Feb 2022
31 Mar 2022 report: 78; public on 16 May 2022
30 Jun 2022 report: 85; public on 15 Aug 2022
30 Sep 2022 report: 83; public on 14 Nov 2022
31 Dec 2022 report: 100; public on 14 Feb 2023
31 Mar 2023 report: 112; public on 15 May 2023
30 Jun 2023 report: 105; public on 14 Aug 2023
30 Sep 2023 report: 101; public on 14 Nov 2023
31 Dec 2023 report: 110; public on 14 Feb 2024
31 Mar 2024 report: 107; public on 15 May 2024
30 Jun 2024 report: 118; public on 14 Aug 2024
30 Sep 2024 report: 128; public on 14 Nov 2024
31 Dec 2024 report: 144; public on 14 Feb 2025
31 Mar 2025 report: 151; public on 15 May 2025
30 Jun 2025 report: 137; public on 14 Aug 2025
30 Sep 2025 report: 138; public on 14 Nov 2025
31 Dec 2025 report: 148; public on 17 Feb 2026
31 Mar 2026 report: 219; public on 15 May 2026
30 Jun 2026 report: 256; public on 14 Aug 2026
30 Sep 2026 report: 270; public on 16 Nov 2026

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is insider open-market selling (USD, Form 4) at $1.3M (3 Apr 2026), higher than 94% of its own history.
  • Insider net buying (open market): Insiders sold a net $2.3M in the last 12 months (the 12 months before: $0).
  • Capital spending per quarter: Capital spending $8K in the latest quarter, -73% on a year earlier.
  • Institutional holders (13F filers): 270 13F filers reported holding it in the latest 13F quarter, +96% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 25 insider trades

No trades in the last 90 days; the latest was filed 3 Apr 2026. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
3 Apr 2026Ebun GarnerChief Legal OfficerSellplanned in advance (10b5-1); after exercising options80,000$16.40$1.3MForm 4
6 Mar 2026Shannon MorrisChief Medical OfficerSellplanned in advance (10b5-1); after exercising options20,000$15.04$301KForm 4
8 Jan 2026Ebun GarnerGeneral Counsel & Corp. Sec.Sellplanned in advance (10b5-1); after exercising options120,000$5.59$671KForm 4
22 May 2024Alexander W. CasdinDirectorBuy80,000$2.27$182KForm 4
8 Dec 2023Valerie Denise Harding StartDirectorBuy10,000$1.85$18KForm 4
6 Dec 2023Jonathan E LimChairman & CEOBuy1,000,000$1.70$1.7MForm 4
4 Dec 2023Alexander W. CasdinDirectorBuy30,000$1.66$50KForm 4
10 Oct 2023Jonathan E LimChairman & CEOBuy1,000,000$2.03$2.0MForm 4

270 institutions reported shares at the end of Q3 2026, 93% of the shares outstanding; 38 opened a position, 30 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
Frazier Life Sciences Management, L.P.29.5M8.40%$432.1M+4.5M+18%
BlackRock, Inc.23.7M6.76%$348.0M+2.6M+12%
RTW Investments, LP22.4M6.40%$329.1M+4.5M+25%
Venrock Adviser, LLC20.1M5.72%$294.5M+2.2M+12%
T. Rowe Price Investment Management, Inc.17.2M4.90%-4.0M-19%
Vanguard Capital Management LLC13.9M3.96%$203.9M+2.5M+22%
State Street Corp13.8M3.94%$202.6M+1.6M+13%
Siren, L.L.C.13.2M3.76%$193.5M+1.8M+16%
Capital World Investors9.4M2.67%$137.2M+8.7M13 times as many
T. Rowe Price Associates Inc8.7M2.47%+2.4M+38%

Company events

All 13 company events

In 12 months: 2 director or officer changes. Results releases and routine reports are left out.

FiledWhat happenedSource
16 Oct 2026Director or officer change8-K
10 Aug 2026Director or officer change8-K
16 May 2024Signed a major agreement; Restructuring costs announced8-K
28 Mar 2024Signed a major agreementSame filing: sold shares privately8-K
10 Apr 2023Director or officer change8-K
9 Dec 2022Signed a major agreementSame filing: sold shares privately8-K
27 Apr 2022Director or officer change8-K
23 Nov 2021Signed a major agreement8-K

The 5 newest of 164 articles that name the company.

Timeline

Timeline

Changes and notable records, by the date each became public

  1. 16 Oct 2026Filings record

    Director or officer change

  2. 10 Aug 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  3. 10 Aug 2026Filings record

    Director or officer change

  4. 15 May 2026Institutional holdings change

    saw 85 13F filers open a new position in the quarter ended 31 Mar 2026, 3.4× the same quarter last year.

    Same quarter last year: 25; its normal quarter is 23.5.

    See the evidence
    This period
    85 (the quarter ended 31 Mar 2026)
    Normal quarter (median of 8 earlier)
    23.5
    Typical spread (median absolute deviation)
    3
    How far from its usual level
    +13.8
    Same quarter last year
    25
    History used
    1,643 days
    2024-03-31: 192024-06-30: 322024-09-30: 222024-12-31: 202025-03-31: 252025-06-30: 252025-09-30: 162025-12-31: 262026-03-31: 85
    the quarter ended 31 Mar 20268 earlier quartersnormal: 23.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  5. 11 Dec 2024Short interest and volume change

    had 32.2M shares sold short in the 29 Nov 2024 report, 3.6× the same report last year.

    Same report last year: 9.1M; its normal report is 12.5M.

    See the evidence
    This period
    32.2M (the 29 Nov 2024 report)
    Normal report (median of 24 earlier)
    12.5M
    Typical spread (median absolute deviation)
    3.5M
    How far from its usual level
    +3.8
    Same report last year
    9.1M
    History used
    1,218 days
    2023-11-30: 9.1M2023-12-15: 11.0M2023-12-29: 9.6M2024-01-12: 10.3M2024-01-31: 10.2M2024-02-15: 10.3M2024-02-29: 9.9M2024-03-15: 9.0M2024-03-28: 8.9M2024-04-15: 9.5M2024-04-30: 10.5M2024-05-15: 10.7M2024-05-31: 14.1M2024-06-14: 15.3M2024-06-28: 20.0M2024-07-15: 21.8M2024-07-31: 22.3M2024-08-15: 23.4M2024-08-30: 24.8M2024-09-13: 27.0M2024-09-30: 33.7M2024-10-15: 33.7M2024-10-31: 33.0M2024-11-15: 32.1M2024-11-29: 32.2M
    the 29 Nov 2024 report24 earlier reportsnormal: 12.5M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  6. 27 Nov 2024Short interest and volume change

    had 32.1M shares sold short in the 15 Nov 2024 report, 3.7× the same report last year.

    Same report last year: 8.7M; its normal report is 10.9M.

    See the evidence
    This period
    32.1M (the 15 Nov 2024 report)
    Normal report (median of 24 earlier)
    10.9M
    Typical spread (median absolute deviation)
    2.1M
    How far from its usual level
    +6.9
    Same report last year
    8.7M
    History used
    1,204 days
    2023-11-15: 8.7M2023-11-30: 9.1M2023-12-15: 11.0M2023-12-29: 9.6M2024-01-12: 10.3M2024-01-31: 10.2M2024-02-15: 10.3M2024-02-29: 9.9M2024-03-15: 9.0M2024-03-28: 8.9M2024-04-15: 9.5M2024-04-30: 10.5M2024-05-15: 10.7M2024-05-31: 14.1M2024-06-14: 15.3M2024-06-28: 20.0M2024-07-15: 21.8M2024-07-31: 22.3M2024-08-15: 23.4M2024-08-30: 24.8M2024-09-13: 27.0M2024-09-30: 33.7M2024-10-15: 33.7M2024-10-31: 33.0M2024-11-15: 32.1M
    the 15 Nov 2024 report24 earlier reportsnormal: 10.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  7. 13 Nov 2024Short interest and volume change

    had 33.0M shares sold short in the 31 Oct 2024 report, 4.2× the same report last year.

    Same report last year: 7.9M; its normal report is 10.6M.

    See the evidence
    This period
    33.0M (the 31 Oct 2024 report)
    Normal report (median of 24 earlier)
    10.6M
    Typical spread (median absolute deviation)
    1.8M
    How far from its usual level
    +8.3
    Same report last year
    7.9M
    History used
    1,189 days
    2023-10-31: 7.9M2023-11-15: 8.7M2023-11-30: 9.1M2023-12-15: 11.0M2023-12-29: 9.6M2024-01-12: 10.3M2024-01-31: 10.2M2024-02-15: 10.3M2024-02-29: 9.9M2024-03-15: 9.0M2024-03-28: 8.9M2024-04-15: 9.5M2024-04-30: 10.5M2024-05-15: 10.7M2024-05-31: 14.1M2024-06-14: 15.3M2024-06-28: 20.0M2024-07-15: 21.8M2024-07-31: 22.3M2024-08-15: 23.4M2024-08-30: 24.8M2024-09-13: 27.0M2024-09-30: 33.7M2024-10-15: 33.7M2024-10-31: 33.0M
    the 31 Oct 2024 report24 earlier reportsnormal: 10.6M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  8. 25 Oct 2024Short interest and volume change

    had 33.7M shares sold short in the 15 Oct 2024 report, 4.6× the same report last year.

    Same report last year: 7.4M; its normal report is 10.4M.

    See the evidence
    This period
    33.7M (the 15 Oct 2024 report)
    Normal report (median of 24 earlier)
    10.4M
    Typical spread (median absolute deviation)
    1.6M
    How far from its usual level
    +9.7
    Same report last year
    7.4M
    History used
    1,173 days
    2023-10-13: 7.4M2023-10-31: 7.9M2023-11-15: 8.7M2023-11-30: 9.1M2023-12-15: 11.0M2023-12-29: 9.6M2024-01-12: 10.3M2024-01-31: 10.2M2024-02-15: 10.3M2024-02-29: 9.9M2024-03-15: 9.0M2024-03-28: 8.9M2024-04-15: 9.5M2024-04-30: 10.5M2024-05-15: 10.7M2024-05-31: 14.1M2024-06-14: 15.3M2024-06-28: 20.0M2024-07-15: 21.8M2024-07-31: 22.3M2024-08-15: 23.4M2024-08-30: 24.8M2024-09-13: 27.0M2024-09-30: 33.7M2024-10-15: 33.7M
    the 15 Oct 2024 report24 earlier reportsnormal: 10.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  9. 10 Oct 2024Short interest and volume change

    had 33.7M shares sold short in the 30 Sep 2024 report, 4.6× the same report last year.

    Same report last year: 7.4M; its normal report is 10.3M.

    See the evidence
    This period
    33.7M (the 30 Sep 2024 report)
    Normal report (median of 24 earlier)
    10.3M
    Typical spread (median absolute deviation)
    1.5M
    How far from its usual level
    +10.5
    Same report last year
    7.4M
    History used
    1,158 days
    2023-09-29: 7.4M2023-10-13: 7.4M2023-10-31: 7.9M2023-11-15: 8.7M2023-11-30: 9.1M2023-12-15: 11.0M2023-12-29: 9.6M2024-01-12: 10.3M2024-01-31: 10.2M2024-02-15: 10.3M2024-02-29: 9.9M2024-03-15: 9.0M2024-03-28: 8.9M2024-04-15: 9.5M2024-04-30: 10.5M2024-05-15: 10.7M2024-05-31: 14.1M2024-06-14: 15.3M2024-06-28: 20.0M2024-07-15: 21.8M2024-07-31: 22.3M2024-08-15: 23.4M2024-08-30: 24.8M2024-09-13: 27.0M2024-09-30: 33.7M
    the 30 Sep 2024 report24 earlier reportsnormal: 10.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  10. 25 Sep 2024Short interest and volume change

    had 27.0M shares sold short in the 13 Sep 2024 report, 3.2× the same report last year.

    Same report last year: 8.4M; its normal report is 10.2M.

    See the evidence
    This period
    27.0M (the 13 Sep 2024 report)
    Normal report (median of 24 earlier)
    10.2M
    Typical spread (median absolute deviation)
    1.5M
    How far from its usual level
    +7.8
    Same report last year
    8.4M
    History used
    1,141 days
    2023-09-15: 8.4M2023-09-29: 7.4M2023-10-13: 7.4M2023-10-31: 7.9M2023-11-15: 8.7M2023-11-30: 9.1M2023-12-15: 11.0M2023-12-29: 9.6M2024-01-12: 10.3M2024-01-31: 10.2M2024-02-15: 10.3M2024-02-29: 9.9M2024-03-15: 9.0M2024-03-28: 8.9M2024-04-15: 9.5M2024-04-30: 10.5M2024-05-15: 10.7M2024-05-31: 14.1M2024-06-14: 15.3M2024-06-28: 20.0M2024-07-15: 21.8M2024-07-31: 22.3M2024-08-15: 23.4M2024-08-30: 24.8M2024-09-13: 27.0M
    the 13 Sep 2024 report24 earlier reportsnormal: 10.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  11. 12 Sep 2024Short interest and volume change

    had 24.8M shares sold short in the 30 Aug 2024 report, 2.8× the same report last year.

    Same report last year: 8.9M; its normal report is 10.1M.

    See the evidence
    This period
    24.8M (the 30 Aug 2024 report)
    Normal report (median of 24 earlier)
    10.1M
    Typical spread (median absolute deviation)
    1.2M
    How far from its usual level
    +8.5
    Same report last year
    8.9M
    History used
    1,127 days
    2023-08-31: 8.9M2023-09-15: 8.4M2023-09-29: 7.4M2023-10-13: 7.4M2023-10-31: 7.9M2023-11-15: 8.7M2023-11-30: 9.1M2023-12-15: 11.0M2023-12-29: 9.6M2024-01-12: 10.3M2024-01-31: 10.2M2024-02-15: 10.3M2024-02-29: 9.9M2024-03-15: 9.0M2024-03-28: 8.9M2024-04-15: 9.5M2024-04-30: 10.5M2024-05-15: 10.7M2024-05-31: 14.1M2024-06-14: 15.3M2024-06-28: 20.0M2024-07-15: 21.8M2024-07-31: 22.3M2024-08-15: 23.4M2024-08-30: 24.8M
    the 30 Aug 2024 report24 earlier reportsnormal: 10.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  12. 27 Aug 2024Short interest and volume change

    had 23.4M shares sold short in the 15 Aug 2024 report, 2.7× the same report last year.

    Same report last year: 8.8M; its normal report is 9.8M.

    See the evidence
    This period
    23.4M (the 15 Aug 2024 report)
    Normal report (median of 24 earlier)
    9.8M
    Typical spread (median absolute deviation)
    959K
    How far from its usual level
    +9.6
    Same report last year
    8.8M
    History used
    1,112 days
    2023-08-15: 8.8M2023-08-31: 8.9M2023-09-15: 8.4M2023-09-29: 7.4M2023-10-13: 7.4M2023-10-31: 7.9M2023-11-15: 8.7M2023-11-30: 9.1M2023-12-15: 11.0M2023-12-29: 9.6M2024-01-12: 10.3M2024-01-31: 10.2M2024-02-15: 10.3M2024-02-29: 9.9M2024-03-15: 9.0M2024-03-28: 8.9M2024-04-15: 9.5M2024-04-30: 10.5M2024-05-15: 10.7M2024-05-31: 14.1M2024-06-14: 15.3M2024-06-28: 20.0M2024-07-15: 21.8M2024-07-31: 22.3M2024-08-15: 23.4M
    the 15 Aug 2024 report24 earlier reportsnormal: 9.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  13. 10 Aug 2024Short interest and volume change

    had 22.3M shares sold short in the 31 Jul 2024 report, 2.1× the same report last year.

    Same report last year: 10.6M; its normal report is 9.8M.

    See the evidence
    This period
    22.3M (the 31 Jul 2024 report)
    Normal report (median of 24 earlier)
    9.8M
    Typical spread (median absolute deviation)
    922K
    How far from its usual level
    +9.1
    Same report last year
    10.6M
    History used
    1,097 days
    2023-07-31: 10.6M2023-08-15: 8.8M2023-08-31: 8.9M2023-09-15: 8.4M2023-09-29: 7.4M2023-10-13: 7.4M2023-10-31: 7.9M2023-11-15: 8.7M2023-11-30: 9.1M2023-12-15: 11.0M2023-12-29: 9.6M2024-01-12: 10.3M2024-01-31: 10.2M2024-02-15: 10.3M2024-02-29: 9.9M2024-03-15: 9.0M2024-03-28: 8.9M2024-04-15: 9.5M2024-04-30: 10.5M2024-05-15: 10.7M2024-05-31: 14.1M2024-06-14: 15.3M2024-06-28: 20.0M2024-07-15: 21.8M2024-07-31: 22.3M
    the 31 Jul 2024 report24 earlier reportsnormal: 9.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  14. 25 Jul 2024Short interest and volume change

    had 21.8M shares sold short in the 15 Jul 2024 report, 2.0× the same report last year.

    Same report last year: 10.8M; its normal report is 9.8M.

    See the evidence
    This period
    21.8M (the 15 Jul 2024 report)
    Normal report (median of 24 earlier)
    9.8M
    Typical spread (median absolute deviation)
    922K
    How far from its usual level
    +8.8
    Same report last year
    10.8M
    History used
    1,081 days
    2023-07-14: 10.8M2023-07-31: 10.6M2023-08-15: 8.8M2023-08-31: 8.9M2023-09-15: 8.4M2023-09-29: 7.4M2023-10-13: 7.4M2023-10-31: 7.9M2023-11-15: 8.7M2023-11-30: 9.1M2023-12-15: 11.0M2023-12-29: 9.6M2024-01-12: 10.3M2024-01-31: 10.2M2024-02-15: 10.3M2024-02-29: 9.9M2024-03-15: 9.0M2024-03-28: 8.9M2024-04-15: 9.5M2024-04-30: 10.5M2024-05-15: 10.7M2024-05-31: 14.1M2024-06-14: 15.3M2024-06-28: 20.0M2024-07-15: 21.8M
    the 15 Jul 2024 report24 earlier reportsnormal: 9.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  15. 11 Jul 2024Short interest and volume change

    had 20.0M shares sold short in the 28 Jun 2024 report, 1.8× the same report last year.

    Same report last year: 10.9M; its normal report is 9.8M.

    See the evidence
    This period
    20.0M (the 28 Jun 2024 report)
    Normal report (median of 24 earlier)
    9.8M
    Typical spread (median absolute deviation)
    922K
    How far from its usual level
    +7.5
    Same report last year
    10.9M
    History used
    1,064 days
    2023-06-30: 10.9M2023-07-14: 10.8M2023-07-31: 10.6M2023-08-15: 8.8M2023-08-31: 8.9M2023-09-15: 8.4M2023-09-29: 7.4M2023-10-13: 7.4M2023-10-31: 7.9M2023-11-15: 8.7M2023-11-30: 9.1M2023-12-15: 11.0M2023-12-29: 9.6M2024-01-12: 10.3M2024-01-31: 10.2M2024-02-15: 10.3M2024-02-29: 9.9M2024-03-15: 9.0M2024-03-28: 8.9M2024-04-15: 9.5M2024-04-30: 10.5M2024-05-15: 10.7M2024-05-31: 14.1M2024-06-14: 15.3M2024-06-28: 20.0M
    the 28 Jun 2024 report24 earlier reportsnormal: 9.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  16. 27 Jun 2024Short interest and volume change

    had 15.3M shares sold short in the 14 Jun 2024 report, 1.6× the same report last year.

    Same report last year: 9.8M; its normal report is 9.7M.

    See the evidence
    This period
    15.3M (the 14 Jun 2024 report)
    Normal report (median of 24 earlier)
    9.7M
    Typical spread (median absolute deviation)
    852K
    How far from its usual level
    +4.4
    Same report last year
    9.8M
    History used
    1,050 days
    2023-06-15: 9.8M2023-06-30: 10.9M2023-07-14: 10.8M2023-07-31: 10.6M2023-08-15: 8.8M2023-08-31: 8.9M2023-09-15: 8.4M2023-09-29: 7.4M2023-10-13: 7.4M2023-10-31: 7.9M2023-11-15: 8.7M2023-11-30: 9.1M2023-12-15: 11.0M2023-12-29: 9.6M2024-01-12: 10.3M2024-01-31: 10.2M2024-02-15: 10.3M2024-02-29: 9.9M2024-03-15: 9.0M2024-03-28: 8.9M2024-04-15: 9.5M2024-04-30: 10.5M2024-05-15: 10.7M2024-05-31: 14.1M2024-06-14: 15.3M
    the 14 Jun 2024 report24 earlier reportsnormal: 9.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  17. 12 Jun 2024Short interest and volume change

    had 14.1M shares sold short in the 31 May 2024 report, 1.4× the same report last year.

    Same report last year: 10.2M; its normal report is 9.7M.

    See the evidence
    This period
    14.1M (the 31 May 2024 report)
    Normal report (median of 24 earlier)
    9.7M
    Typical spread (median absolute deviation)
    820K
    How far from its usual level
    +3.6
    Same report last year
    10.2M
    History used
    1,036 days
    2023-05-31: 10.2M2023-06-15: 9.8M2023-06-30: 10.9M2023-07-14: 10.8M2023-07-31: 10.6M2023-08-15: 8.8M2023-08-31: 8.9M2023-09-15: 8.4M2023-09-29: 7.4M2023-10-13: 7.4M2023-10-31: 7.9M2023-11-15: 8.7M2023-11-30: 9.1M2023-12-15: 11.0M2023-12-29: 9.6M2024-01-12: 10.3M2024-01-31: 10.2M2024-02-15: 10.3M2024-02-29: 9.9M2024-03-15: 9.0M2024-03-28: 8.9M2024-04-15: 9.5M2024-04-30: 10.5M2024-05-15: 10.7M2024-05-31: 14.1M
    the 31 May 2024 report24 earlier reportsnormal: 9.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  18. 23 May 2024Insiders record

    Casdin Alexander W. (director) bought 80,000 shares of ERAS ($181,600) (dated 22 May 2024)

  19. 16 May 2024Filings record

    Restructuring costs announced

  20. 9 Dec 2023Insiders change

    had 3 insiders buy $1.8M of its shares on the open market within 30 days (3 filings).

    Who bought: Casdin Alexander W., Lim Jonathan E, Start Valerie Denise Harding.

    See the evidence (3 source records)
    Independent buyers
    3
    Purchase filings (Form 4, code P)
    3
    Total bought
    $1.8M
    Window
    9 Nov 2023 to 9 Dec 2023

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

  21. 9 Dec 2023Insiders record

    Start Valerie Denise Harding (director) bought 10,000 shares of ERAS ($18,500) (dated 8 Dec 2023)

  22. 7 Dec 2023Insiders record

    Lim Jonathan E (Chairman & CEO) bought 1,000,000 shares of ERAS ($1.7M) (dated 6 Dec 2023)

  23. 5 Dec 2023Insiders record

    Casdin Alexander W. (director) bought 30,000 shares of ERAS ($49,800) (dated 4 Dec 2023)

  24. 11 Oct 2023Insiders record

    Lim Jonathan E (Chairman & CEO) bought 1,000,000 shares of ERAS ($2.0M) (dated 10 Oct 2023)

  25. 9 Jun 2023Insiders record

    Lim Jonathan E (Chairman & CEO) bought 100,000 shares of ERAS ($275,000) (dated 8 Jun 2023)

  26. 12 Apr 2023Insiders record

    Casdin Alexander W. (director) bought 20,000 shares of ERAS ($55,200) (dated 11 Apr 2023)

  27. 10 Apr 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  28. 10 Apr 2023Filings record

    Director or officer change

  29. 29 Mar 2023Insiders record

    Lim Jonathan E (Chairman & CEO) bought 100,000 shares of ERAS ($284,000) (dated 28 Mar 2023)

  30. 11 Jan 2023Insiders record

    Lim Jonathan E (Chairman & CEO) bought 60,000 shares of ERAS ($231,600) (dated 10 Jan 2023)

  31. 23 Dec 2022Insiders record

    Bristol James Arthur (director) bought 20,000 shares of ERAS ($82,800) (dated 22 Dec 2022)

  32. 23 Dec 2022Insiders record

    Start Valerie Denise Harding (director) bought 10,000 shares of ERAS ($46,400) (dated 22 Dec 2022)

  33. 22 Dec 2022Insiders record

    Cormorant Asset Management, LP (director) and 3 other(s) bought 307,692 shares of ERAS [amended] [same transaction as an earlier filing] (dated 21 Dec 2022)

  34. 21 Dec 2022Insiders change

    had 3 insiders buy $2.3M of its shares on the open market within 30 days (3 filings).

    Who bought: Lim Jonathan E, Casdin Alexander W..

    See the evidence (3 source records)
    Independent buyers
    3
    Purchase filings (Form 4, code P)
    3
    Total bought
    $2.3M
    Window
    21 Nov 2022 to 21 Dec 2022

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

  35. 21 Dec 2022Insiders record

    Cormorant Asset Management, LP (director) and 3 other(s) bought 307,692 shares of ERAS ($2.0M) (dated 20 Dec 2022)

  36. 16 Dec 2022Insiders record

    Casdin Alexander W. (director) bought 20,000 shares of ERAS ($97,400) (dated 15 Dec 2022)

  37. 16 Dec 2022Insiders record

    Lim Jonathan E (Chairman & CEO) bought 40,000 shares of ERAS ($199,600) (dated 15 Dec 2022)

  38. 27 Apr 2022Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  39. 27 Apr 2022Filings record

    Director or officer change

  40. 11 Aug 2021Insiders record

    Chen Bihua (director) bought 200,000 shares of ERAS ($4.4M) (dated 10 Aug 2021)

Showing the newest 40 of 50 entries; narrow the window or the kind of data to see older ones.

Not listed: 78 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001761918
Ticker
ERAS
Domain
erasca.com
Hq location
CA|SAN DIEGO|92121 (1 unverified)
Name
Erasca, Inc.
  • SEC Form 13F institutional holdings189 data points30 Sep 2021 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)83 records15 Jan 2019 to 20 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)381 data points31 Dec 2019 to 5 Nov 2026
  • SEC Form 4 insider transactions25 records, 72 data points20 Jul 2021 to 3 Apr 2026
  • FINRA short interest (twice monthly)377 data points30 Jul 2021 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)2690 data points16 Jul 2021 to 20 Nov 2026